Chiang J. Li

3.6k total citations · 1 hit paper
42 papers, 2.8k citations indexed

About

Chiang J. Li is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Chiang J. Li has authored 42 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 13 papers in Oncology and 6 papers in Toxicology. Recurrent topics in Chiang J. Li's work include RNA Interference and Gene Delivery (15 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Cancer Cells and Metastasis (7 papers). Chiang J. Li is often cited by papers focused on RNA Interference and Gene Delivery (15 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Cancer Cells and Metastasis (7 papers). Chiang J. Li collaborates with scholars based in United States, South Korea and Japan. Chiang J. Li's co-authors include Arthur B. Pardee, Youzhi Li, Valeri Metelev, Chuanlin Wang, David J. Friedman, Harry A. Rogoff, Shuanglin Xiang, Xiangao Sun, Johannes Fruehauf and António Pinto and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Chiang J. Li

42 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of cancer relapse and metastasis by inhibiting cancer stemness

2015 382 citations Youzhi Li, Harry A. Rogoff et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chiang J. Li United States	21	1.7k	712	448	439	415	42	2.8k
Mark T. Muller United States	38	2.8k 1.7×	802 1.1×	106 0.2×	268 0.6×	337 0.8×	88	3.8k
Osamu Koiwai Japan	31	1.9k 1.1×	496 0.7×	47 0.1×	384 0.9×	85 0.2×	96	3.1k
Katerina V. Gurova United States	34	2.3k 1.4×	823 1.2×	107 0.2×	292 0.7×	61 0.1×	84	3.1k
Lorenzo M. Leoni United States	30	1.8k 1.1×	817 1.1×	350 0.8×	758 1.7×	22 0.1×	57	3.7k
K Paull United States	10	1.5k 0.9×	925 1.3×	86 0.2×	121 0.3×	116 0.3×	13	2.3k
Maurizio Cianfriglia Italy	29	1.3k 0.8×	1.2k 1.6×	215 0.5×	340 0.8×	31 0.1×	100	2.5k
Paul Payette Canada	20	1.3k 0.8×	220 0.3×	86 0.2×	1.4k 3.2×	69 0.2×	24	2.9k
Euphemia Leung New Zealand	35	2.2k 1.3×	815 1.1×	43 0.1×	1.2k 2.8×	74 0.2×	160	4.3k
Jeng‐Pyng Shaw United States	18	1.1k 0.7×	243 0.3×	224 0.5×	516 1.2×	23 0.1×	29	2.2k
Yves Collette France	36	1.7k 1.0×	621 0.9×	776 1.7×	1.5k 3.3×	21 0.1×	90	3.6k

Countries citing papers authored by Chiang J. Li

Since Specialization

Citations

This map shows the geographic impact of Chiang J. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiang J. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiang J. Li more than expected).

Fields of papers citing papers by Chiang J. Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiang J. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiang J. Li. The network helps show where Chiang J. Li may publish in the future.

Co-authorship network of co-authors of Chiang J. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chiang J. Li. A scholar is included among the top collaborators of Chiang J. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiang J. Li. Chiang J. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pardee, Arthur B. & Chiang J. Li. (2018). Two controls of cell proliferation underlie cancer relapse. Journal of Cellular Physiology. 233(11). 8437–8440. 7 indexed citations

Murata, Masashi, Simon J. Dovedi, Robert W. Wilkinson, et al.. (2015). TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice. Cancer Immunology Immunotherapy. 64(10). 1229–1239. 19 indexed citations

Ghisolfi, Laura, Andrew C. Keates, Xingwang Hu, Dong-ki Lee, & Chiang J. Li. (2012). Ionizing Radiation Induces Stemness in Cancer Cells. PLoS ONE. 7(8). e43628–e43628. 136 indexed citations

Hu, Xingwang, Laura Ghisolfi, Andrew C. Keates, et al.. (2012). Induction of cancer cell stemness by chemotherapy. Cell Cycle. 11(14). 2691–2698. 84 indexed citations

Dua, Pooja, et al.. (2011). Long Double-Stranded RNA-Mediated RNA Interference and Immunostimulation: Long Interfering Double-Stranded RNA as a Potent Anticancer Therapeutics. Nucleic Acid Therapeutics. 21(3). 149–155. 11 indexed citations

Munshi, Neru, Sébastien Jeay, Youzhi Li, et al.. (2010). ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity. Molecular Cancer Therapeutics. 9(6). 1544–1553. 274 indexed citations

Langleben, Adrian, Jeffrey G. Supko, Sébastien J. Hotte, et al.. (2010). Abstract LB-171: A phase 1 dose escalation study of BBI608, a first-in-class cancer stem cell pathway inhibitor in patients with advanced malignancies. Cancer Research. 70(8_Supplement). LB–171. 1 indexed citations

Zhang, Bin, et al.. (2008). High-Content Fluorescent-Based Assay for Screening Activators of DNA Damage Checkpoint Pathways. SLAS DISCOVERY. 13(6). 538–543. 11 indexed citations

Sun, Xiangao, Harry A. Rogoff, & Chiang J. Li. (2008). Asymmetric RNA duplexes mediate RNA interference in mammalian cells. Nature Biotechnology. 26(12). 1379–1382. 94 indexed citations

10.

Keates, Andrew C., et al.. (2007). Cequent Pharmaceuticals, Inc.: The Biological Pitcher for RNAi Therapeutics. Pharmacogenomics. 8(7). 867–871. 6 indexed citations

11.

Xiang, Shuanglin, Johannes Fruehauf, & Chiang J. Li. (2006). Short hairpin RNA–expressing bacteria elicit RNA interference in mammals. Nature Biotechnology. 24(6). 697–702. 196 indexed citations

12.

Li, Chiang J.. (2006). Therapeutic biology: Checkpoint pathway activation therapy, HIV Tat, and transkingdom RNA interference. Journal of Cellular Physiology. 209(3). 695–700. 5 indexed citations

13.

Sun, Xiangao, Youzhi Li, Wěi Li, et al.. (2006). Selective Induction of Necrotic Cell Death in Cancer Cells by β-Lapachone through Activation of DNA Damage Response Pathway. Cell Cycle. 5(17). 2029–2035. 26 indexed citations

14.

Fruehauf, Johannes, et al.. (2006). Genomic Instability in Precancerous Lesions before Inactivation of Tumor Suppressors p53 and APC in Patients. Cell Cycle. 5(13). 1443–1447. 12 indexed citations

15.

Chen, Chang-Rung, et al.. (2005). Dual Induction of Apoptosis and Senescence in Cancer Cells by Chk2 Activation: Checkpoint Activation as a Strategy against Cancer. Cancer Research. 65(14). 6017–6021. 41 indexed citations

16.

Li, Youzhi, Chiang J. Li, Donghui Yu, & Arthur B. Pardee. (2000). Potent Induction of Apoptosis by β-Lapachone in Human Multiple Myeloma Cell Lines and Patient Cells. Molecular Medicine. 6(12). 1008–1015. 46 indexed citations

17.

Li, Chiang J., Youzhi Li, António Pinto, & Arthur B. Pardee. (1999). Potent inhibition of tumor survivalin vivoby β-lapachone plus taxol: Combining drugs imposes different artificial checkpoints. Proceedings of the National Academy of Sciences. 96(23). 13369–13374. 152 indexed citations

18.

Li, Chiang J., Yutaka Ueda, Bin Shi, et al.. (1997). Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proceedings of the National Academy of Sciences. 94(15). 8116–8120. 98 indexed citations

19.

Li, Chiang J., David J. Friedman, Chuanlin Wang, Valeri Metelev, & Arthur B. Pardee. (1995). Induction of Apoptosis in Uninfected Lymphocytes by HIV-1 Tat Protein. Science. 268(5209). 429–431. 497 indexed citations

20.

Li, Chiang J., Bruce J. Dezube, Debajit K. Biswas, Christoph M. Ahlers, & Arthur B. Pardee. (1994). Inhibitors of HIV-1 transcription. Trends in Microbiology. 2(5). 164–169. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact